"Einstein Medical Center Montgomery provides a full range of medical care and surgical interventions delivered by a highly skilled medical team. Located on 87 acres along Germantown Pike in East Norriton, Pa., Einstein Medical Center Montgomery brings the exceptional experience of Einstein Healthcare Network to residents of central Montgomery County."

During the past decade, Einstein Medical Center Montgomery conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 2 clinical trials were completed, i.e. on average, 40% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Einstein Medical Center Montgomery" #1 collaborator was "NRG Oncology" with 2 trials as a collaborator, "National Cancer Institute (NCI)" with 2 trials as a collaborator, "Canadian Cancer Trials Group" with 1 trials as a collaborator, "Division of Cancer Control" with 1 trials as a collaborator and "NIH Biomarker, Imaging and Quality of Life Studies Funding Program (BIQSFP)" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "Einstein Medical Center Montgomery" are "Stage IB Lung Non-Small Cell Carcinoma AJCC v7" (2 trials), "Stage II Lung Non-Small Cell Cancer AJCC v7" (2 trials), "Stage IIA Lung Non-Small Cell Carcinoma AJCC v7" (2 trials), "Stage IIB Lung Non-Small Cell Carcinoma AJCC v7" (2 trials) and "Stage IIIA Lung Non-Small Cell Cancer AJCC v7" (2 trials). Many other conditions were trialed in "Einstein Medical Center Montgomery" in a lesser frequency.

Most popular intervention types in "Einstein Medical Center Montgomery" are "Other" (6 trials), "Drug" (4 trials), "Biological" (3 trials), "Device" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (4 trials), "Clinical Observation" (3 trials), "Crizotinib" (2 trials), "Paclitaxel" (2 trials) and "Placebo Administration" (2 trials). Other intervention names were less common.

The vast majority of trials in "Einstein Medical Center Montgomery" are 4 trials for "All" genders and 3 trials for "Female" genders.

Currently, there are NaN active trials in "Einstein Medical Center Montgomery". undefined are not yet recruiting, 3 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Einstein Medical Center Montgomery, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Einstein Medical Center Montgomery, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".